Early intervention with Bifidobacterium lactis NCC2818 modulates the host-microbe interface independent of the sustained changes induced by the neonatal environment

• Published in: Scientific reports Vol. 7; no. 1; pp. 5310 - 14
• Main Authors: Lewis, Marie C., Merrifield, Claire A., Berger, Bernard, Cloarec, Olivier, Duncker, Swantje, Mercenier, Annick, Nicholson, Jeremy K., Holmes, Elaine, Bailey, Mick
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 13.07.2017; Nature Publishing Group; Nature Portfolio
• Subjects: 13/1; 13/106; 13/51; 14/63; 140/131; 45; 45/22; 45/23; 631/250/347; 631/326/2565/2134; 631/92/320; 64; Alanine; Animals; Animals, Newborn; Bifidobacterium animalis - growth & development; Cytokines; Early Intervention (Education); Environmental Exposure; Gastrointestinal Microbiome; Humanities and Social Sciences; Immunity, Mucosal; Immunoglobulin M; Infants; Interleukin 10; Interleukin 17; Interleukin 4; Intestine; Metabolic Diseases - prevention & control; Metabolic disorders; Metabolites; Mucosal immunity; multidisciplinary; Neonates; Probiotics - administration & dosage; Science; Science (multidisciplinary); Supplements; Swine; Swine Diseases - prevention & control; Systemic Inflammatory Response Syndrome - prevention & control
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-017-05689-z

Inflammatory and metabolic diseases can originate during early-life and have been correlated with shifts in intestinal microbial ecology. Here we demonstrate that minor environmental fluctuations during the early neonatal period had sustained effects on the developing porcine microbiota and host-microbe interface. These inter-replicate effects appear to originate during the first day of life, and are likely to reflect very early microbiota acquisition from the environment. We statistically link early systemic inflammation with later local increases in inflammatory cytokine (IL-17) production, which could have important enteric health implications. Immunity, intestinal barrier function, host metabolism and host-microbiota co-metabolism were further modified by Bifidobacterium lactis NCC2818 supplementation, although composition of the in situ microbiota remained unchanged. Finally, our robust model identified novel, strong correlations between urinary metabolites (eg malonate, phenylacetylglycine, alanine) and mucosal immunoglobulin (IgM) and cytokine (IL-10, IL-4) production, thus providing the possibility of the development of urinary ‘dipstick’ tests to assess non-accessible mucosal immune development and identify early precursors (biomarkers) of disease. These results have important implications for infants exposed to neonatal factors including caesarean delivery, antibiotic therapy and delayed discharge from hospital environments, which may predispose to the development of inflammatory and metabolic diseases in later life.